Market Cap 11.54M
Revenue (ttm) 0.00
Net Income (ttm) 1.44M
EPS (ttm) N/A
PE Ratio 2.11
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 9,200
Avg Vol 9,718
Day's Range N/A - N/A
Shares Out 6.99M
Stochastic %K 27%
Beta -0.34
Analysts Hold
Price Target $5.00

Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neur...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 600 7373
Address:
1500 District Avenue, Burlington, United States
Stockstockerr
Stockstockerr Jun. 10 at 2:52 PM
$ALT looking good $DMN is the really money maker in the long run $RUN now that $NERV is on hold what will happen to this one?
0 · Reply
Stockstockerr
Stockstockerr Jun. 10 at 7:04 AM
$NERV $RGS 626% since this post 🤣
0 · Reply
StockHolder2025
StockHolder2025 Jun. 4 at 10:27 AM
$NERV time to fly 🚀🚀🚀
0 · Reply
ka1954
ka1954 May. 22 at 8:23 PM
$NERV how long will this stock remain dead?
2 · Reply
FlicFlac
FlicFlac May. 15 at 11:41 AM
$NERV no never proper communication from the company.. disappointing :(
0 · Reply
GrindTime
GrindTime May. 14 at 7:19 PM
$NERV oof?
0 · Reply
stocklion2
stocklion2 Apr. 16 at 6:11 AM
$NERV The company trading under the symbol $ NOVA has a net asset value of $2.7 billion, yet it’s currently sitting at a market cap of just $30 million. These shares are massively undervalued — grab them while they’re still cheap!
0 · Reply
PenkeTrading
PenkeTrading Apr. 16 at 4:47 AM
I found you a Bearish Engulfing Candle Pattern on the daily chart of Minerva Neurosciences Inc. $NERV #BearishEngulfingCandle #NASDAQ
0 · Reply
ka1954
ka1954 Apr. 9 at 1:39 PM
$NERV stop selling u idiots !!! if nobody sells this can rally
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 10:58 AM
$NERV FDA threw major curveball with CRL. Roluperidone needs more work but potential still looks promising. Watching closely for next steps in schizophrenia treatment development. Might add small position if they navigate regulatory hurdles effectively. standout article: https://beyondspx.com/article/minerva-neurosciences-navigating-challenges-in-cns-drug-development
0 · Reply
Latest News on NERV
Minerva Neurosciences: There's Probably Time For One More Rally

Aug 23, 2023, 4:05 AM EDT - 2 years ago

Minerva Neurosciences: There's Probably Time For One More Rally


Stockstockerr
Stockstockerr Jun. 10 at 2:52 PM
$ALT looking good $DMN is the really money maker in the long run $RUN now that $NERV is on hold what will happen to this one?
0 · Reply
Stockstockerr
Stockstockerr Jun. 10 at 7:04 AM
$NERV $RGS 626% since this post 🤣
0 · Reply
StockHolder2025
StockHolder2025 Jun. 4 at 10:27 AM
$NERV time to fly 🚀🚀🚀
0 · Reply
ka1954
ka1954 May. 22 at 8:23 PM
$NERV how long will this stock remain dead?
2 · Reply
FlicFlac
FlicFlac May. 15 at 11:41 AM
$NERV no never proper communication from the company.. disappointing :(
0 · Reply
GrindTime
GrindTime May. 14 at 7:19 PM
$NERV oof?
0 · Reply
stocklion2
stocklion2 Apr. 16 at 6:11 AM
$NERV The company trading under the symbol $ NOVA has a net asset value of $2.7 billion, yet it’s currently sitting at a market cap of just $30 million. These shares are massively undervalued — grab them while they’re still cheap!
0 · Reply
PenkeTrading
PenkeTrading Apr. 16 at 4:47 AM
I found you a Bearish Engulfing Candle Pattern on the daily chart of Minerva Neurosciences Inc. $NERV #BearishEngulfingCandle #NASDAQ
0 · Reply
ka1954
ka1954 Apr. 9 at 1:39 PM
$NERV stop selling u idiots !!! if nobody sells this can rally
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 10:58 AM
$NERV FDA threw major curveball with CRL. Roluperidone needs more work but potential still looks promising. Watching closely for next steps in schizophrenia treatment development. Might add small position if they navigate regulatory hurdles effectively. standout article: https://beyondspx.com/article/minerva-neurosciences-navigating-challenges-in-cns-drug-development
0 · Reply
NEWLONEWOLF09
NEWLONEWOLF09 Mar. 7 at 8:18 PM
$NERV okay this is dead. so many R/S and I am 95% down.
1 · Reply
ManfredMustermann
ManfredMustermann Mar. 4 at 3:15 PM
$NERV when delisting?
0 · Reply
JarvisFlow
JarvisFlow Feb. 26 at 12:33 PM
HC Wainwright & Co. has adjusted their stance on Minerva Neurosciences ($NERV), setting the rating to Neutral with a target price of 5.
0 · Reply
Dardpro
Dardpro Feb. 26 at 12:13 PM
$NERV dead?
0 · Reply
ka1954
ka1954 Feb. 6 at 10:42 PM
$NERV it has gone beteween 1.50 to 15 in last 3-4 years, that's the range. i think this year it could go back to $10+
0 · Reply
kshonstocks
kshonstocks Feb. 5 at 6:50 PM
$NERV Total Cash Per Share (mrq) 3.79 https://finance.yahoo.com/quote/NERV/key-statistics/ had a yuge block last week
0 · Reply
Tumble51
Tumble51 Jan. 31 at 11:46 AM
$CADL tell that to the chartist at $NERV Stating $21 was next on Friday Oct 12 2022 It opened at $3 Monday morning !!! A chart guru !!! I got out at 13.25 Friday AM !!! Draw whatever lines you want, you don’t sit in the board room or the office of the CEO !!!
1 · Reply
Tradelyfe
Tradelyfe Jan. 30 at 1:42 PM
1 · Reply
Tradelyfe
Tradelyfe Jan. 29 at 10:10 PM
$NERV looks sexy for an explosion
0 · Reply
reversalpicks
reversalpicks Jan. 29 at 5:42 PM
$NERV potential to go up
0 · Reply
PenkeTrading
PenkeTrading Jan. 29 at 1:44 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Minerva Neurosciences Inc. Is that bullish or bearish? $NERV #RsiOverbought #NASDAQ
0 · Reply